Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.
about
Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injuryTraumatic Axonal Injury: Mechanisms and Translational OpportunitiesClinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injuryForce spectroscopy measurements show that cortical neurons exposed to excitotoxic agonists stiffen before showing evidence of bleb damage.Neurodegeneration in the somatosensory cortex after experimental diffuse brain injuryPotential Blood-based Biomarkers for Concussion.Recovery of neurological function despite immediate sleep disruption following diffuse brain injury in the mouse: clinical relevance to medically untreated concussionWhite matter alterations in youth with acute mild traumatic brain injury.Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.The whisker nuisance task identifies a late-onset, persistent sensory sensitivity in diffuse brain-injured ratsDiffuse traumatic brain injury initially attenuates and later expands activation of the rat somatosensory whisker circuit concomitant with neuroplastic responses.Experimental traumatic brain injuryαII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study.Axonal pathology in traumatic brain injury.A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study.Moderately elevated intracranial pressure after diffuse traumatic brain injury is associated with exacerbated neuronal pathology and behavioral morbidity in the rat.Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in ratsChronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophyProteolysis of submembrane cytoskeletal proteins ankyrin-G and αII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier.Comparison of rat sensory behavioral tasks to detect somatosensory morbidity after diffuse brain-injury.SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injuryDisruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury.Guilty molecules, guilty minds? The conflicting roles of the innate immune response to traumatic brain injuryTherapy development for diffuse axonal injury.A military-centered approach to neuroprotection for traumatic brain injury.Mild traumatic brain injury in the mouse induces axotomy primarily within the axon initial segmentCalpain as a therapeutic target in traumatic brain injury.Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.The role of calpains in traumatic brain injury.Neurochemical cascade of concussion.The role of excitotoxic programmed necrosis in acute brain injury.Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus.Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.The Pathophysiology of Concussion.Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists?Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injuryBiomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.
P2860
Q24626804-99BF4752-E30E-409A-891C-BA38D9BC5573Q26753059-0B5C8765-788F-491D-8E8F-D72825461D0CQ28390792-AF5584B5-BD8F-444F-9965-760E1893D212Q30449539-A7708EFC-33D4-4A59-B6BE-AF068D8C7088Q30531301-3494C4EE-8259-4B06-992C-122A9B3D597AQ31119100-253492F1-7CC6-44CC-83B8-0800670F0B57Q33708812-DDEECB90-35AD-4BDD-8CAE-DE14CA044198Q33726964-095D7257-CB63-4254-BD61-33E7F2322BAEQ33793699-4DBC867C-A1DC-4642-9605-D5E7F63C855CQ33841633-458DA9B1-1BCA-4D60-9258-D8A3939C9F8EQ33925907-28D61AF8-DC0C-46A4-8AEE-EE27119E9B8FQ34093983-B50B2835-19BE-488B-8AA8-0855167EEC8CQ34142573-6B015EA4-2F88-4509-9976-893F876B6E55Q34147858-9C2ACBB1-C133-42DF-9D84-DC72CC8D0CB8Q34250254-E0B72726-2D52-4A6A-BF8F-EEB0FA18D558Q34378362-AE1FF87B-3B37-4B36-9EC5-9CB072812BF6Q34538926-47BE1D17-5E14-461B-8DC8-197CC7C0AB48Q34727074-CE21503C-C90B-482A-8CB4-2B7FC156E37BQ35212561-B1A704C4-2EF8-4A66-9553-793BACE42B3AQ35660362-E8F95725-C8CE-4A15-8264-D747D55B2016Q35692390-DD2954E5-6135-4AF5-A263-272BC147F072Q35726966-8F0CA34A-6621-42AD-9238-99BE8889C09CQ35847562-B0CC5E7D-2F8D-40A9-B48C-F5A1059F7872Q35886735-F6406721-6FCA-4D65-9886-138C41DAD8CAQ36026673-071EF56F-7E87-42AA-A4A1-45F0D3C3CE16Q36768885-9EE1ECEF-4A4F-4D5E-9EAB-E67010034CE1Q36920836-68D4DC70-5937-44BA-83ED-5AD4BD7D0E3DQ36951580-1F132C0C-83D0-4347-BD41-0EB49DEB8B0BQ37686765-8A3C77BB-D294-479E-85A7-6497B3B7DF94Q38109663-0FEDEC54-C821-4249-8437-08B8BB85F5E1Q38181174-EE5A2E09-B3A4-48F9-8986-18AEB57BDF6FQ38318040-23C59F3F-0F57-486D-9157-4396A3D617BFQ38429588-A89B90BC-3073-4C66-ABFE-1073D62D39D5Q38775748-6C1CB0C5-8F23-4CBC-82F1-9E4BA4FFCB2CQ38784171-91E89E2A-C558-4BC8-B2FE-96897AE6A039Q38835489-1786AC71-DD66-4D67-BA5B-9E6143C650FDQ41451579-FB5593B0-2C7A-4860-A104-DACA35CAEBCDQ42229910-059CC488-9133-4E35-8ED8-1BFB6237E6C6Q42788353-CA9E63DF-55E2-4611-A597-D54926448579Q44923505-84B8B708-7CDE-414C-8F9B-79A8FEFEC1C5
P2860
Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@en
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@nl
type
label
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@en
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@nl
prefLabel
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@en
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@nl
P2093
P2860
P1476
Biochemical, structural, and b ...... ry uncomplicated by contusion.
@en
P2093
Brian J Kelley
John T Povlishock
Linnet Akinyi
Melissa J McGinn
Ming Cheng Liu
Monika W Oli
Ronald L Hayes
P2860
P304
P356
10.1097/NEN.0B013E3181996BFE
P577
2009-03-01T00:00:00Z